Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics
Titel:
Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics
Auteur:
Mayer, Erica L. Isakoff, Steven J. Klement, Giannoula Downing, Sean R. Chen, Wendy Y. Hannagan, Keri Gelman, Rebecca Winer, Eric P. Burstein, Harold J.